Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Vita 34 AG

Start price
Target price
Perf. (%)
€11.05
18.05.22
-
18.05.23
-0.45%
28.05.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.16
18.05.22
-
18.05.23
2.59%
28.05.22

Could be very worthwhile Investment >20% year
Undervalued
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€471.15
17.05.22
-
17.05.23
-6.19%
17.05.23

buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€30.42
16.05.22
-
16.05.25
-53.44%
11.03.24

Could be worthwhile Investment >10% per year
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€72.88
16.05.22
-
16.05.23
-2.92%
27.05.22

Probably not worthwhile Investment
Business model of the past or high risk
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.60
16.05.22
€3.00
16.05.23
-28.60%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€28.60
16.05.22
-
16.05.23
-14.58%
28.05.22

Risky Investment
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.87
15.05.22
€68.00
15.05.23
32.12%
28.10.22

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.42
15.05.22
-
15.05.23
81.90%
24.04.23

Risky Investment
Growths slower than the competition
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€1.18
15.05.22
-
15.05.23
-19.25%
29.05.22

Could be very worthwhile Investment >20% year
buy
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€7.76
14.05.22
-
14.05.23
-4.60%
28.05.22

Risky Investment
buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€41.80
12.05.22
-
12.05.23
-6.22%
13.05.23

buy
Dottikon ES Holding AG

Start price
Target price
Perf. (%)
€48.00
11.05.22
€54.00
11.05.23
0.00%
11.05.23

Could be very worthwhile Investment >20% year
Small challenges to pay loans and raise capital
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€16.10
07.05.22
€20.00
07.05.23
222.26%
08.05.23

Could be very worthwhile Investment >20% year
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.00
06.05.22
-
06.05.23
-24.17%
15.05.22

Risky Investment
buy
BioLase Inc.

Start price
Target price
Perf. (%)
€4.73
06.05.22
-
06.05.23
-96.11%
06.05.23

Northwest Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.78
05.05.22
-
05.05.23
-70.21%
06.05.23

Risky Investment
buy
Ose Pharma International S.A.

Start price
Target price
Perf. (%)
€7.32
04.05.22
€9.00
04.05.23
-49.42%
05.05.23

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€55.10
03.05.22
€60.00
03.05.23
-22.67%
25.05.22

Very low/no dividend yield expected
very negative Cash Flow expected
ROE lower than 10% per year
high free float
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€36.83
03.05.22
€30.00
03.05.23
-38.60%
11.03.23

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Sonova Holding AG Na.

Start price
Target price
Perf. (%)
€200.00
03.05.22
-
03.05.23
-
03.05.23

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Newegg Commerce Inc.

Start price
Target price
Perf. (%)
€5.95
02.05.22
€12.00
02.05.23
-25.71%
16.05.22

Could be very worthwhile Investment >20% year
buy
Molecular Templates Inc.

Start price
Target price
Perf. (%)
€1.56
01.05.22
-
01.05.23
-24.58%
14.05.22

Risky Investment
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€8.03
01.05.22
-
01.05.23
-12.75%
24.04.23

Risky Investment
Higher risks for its business
High valuation